Top Clinical Trials companies in Sweden by Shareholders' Equity
Sweden
# |
Name |
Shareholders' Equity |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 1.26 B
|
Dec. 31, 2023 | USD 19.80 | -1.20% |
|
Sweden |
|
| 2 |
USD 147.36 M
|
Dec. 31, 2023 | USD 52.33 | -2.11% |
|
Sweden |
|
| 3 |
USD 103.30 M
|
Dec. 31, 2023 | USD 18.98 | -4.07% |
|
Sweden |
|
| 4 |
USD 95.74 M
|
Dec. 31, 2023 | USD 1.59 | -2.74% |
|
Sweden |
|
| 5 |
USD 69.56 M
|
Dec. 31, 2023 | USD 0.71 | 8.98% |
|
Sweden |
|
| 6 |
USD 68.44 M
|
Dec. 31, 2023 | USD 3.06 | 1.23% |
|
Sweden |
|
| 7 |
USD 60.28 M
|
Dec. 31, 2023 | USD 0.85 | -1.32% |
|
Sweden |
|
| 8 |
USD 53.85 M
|
Dec. 31, 2023 | USD 0.54 | -2.24% |
|
Sweden |
|
| 9 |
USD 17.39 M
|
Dec. 31, 2023 | USD 1.26 | -1.32% |
|
Sweden |
|
| 10 |
USD 15.69 M
|
Dec. 31, 2023 | USD 2.27 | -2.64% |
|
Sweden |
|
| 11 |
USD 15.62 M
|
Dec. 31, 2023 | USD 2.77 | -4.78% |
|
Sweden |
|
| 12 |
USD 15.40 M
|
Aug. 31, 2023 | USD 1.49 | -4.08% |
|
Sweden |
|
| 13 |
USD 12.82 M
|
Dec. 31, 2023 | USD 0.18 | -3.03% |
|
Sweden |
|
| 14 |
USD 11.21 M
|
Dec. 31, 2023 | USD 0.39 | -4.99% |
|
Sweden |
|
| 15 |
USD 8.75 M
|
April 30, 2024 | USD 0.18 | -8.41% |
|
Sweden |
|
| 16 |
USD 6.67 M
|
Dec. 31, 2023 | USD 0.62 | -5.18% |
|
Sweden |
|
| 17 |
USD 5.81 M
|
Dec. 31, 2023 | USD 1.64 | -3.31% |
|
Sweden |
|
| 18 |
USD 2.44 M
|
Dec. 31, 2023 | USD 0.76 | -6.55% |
|
Sweden |
Frequently Asked Questions
-
Which Clinical Trials company in Sweden has the highest Shareholders' Equity ?
The Clinical Trials company in Sweden with the highest Shareholders' Equity is Vitrolife AB (publ) (Stockholm Stock Exchange: VITR.ST) at USD 1.26 B.
-
Which Clinical Trials company in Sweden has the lowest Shareholders' Equity ?
The Clinical Trials company in Sweden with the lowest Shareholders' Equity is Prostatype Genomics AB (publ) (Stockholm Stock Exchange: PROGEN.ST) at USD 2.44 M.
-
What are the top 10 Clinical Trials companies in Sweden by Shareholders' Equity ?
The top 10 Clinical Trials companies in Sweden by Shareholders' Equity are Vitrolife AB (publ), Camurus AB (publ), BioArctic AB (publ), Sedana Medical AB (publ), Mendus AB (publ), Xspray Pharma AB (publ), Moberg Pharma AB (publ), Egetis Therapeutics AB (publ), SynAct Pharma AB and Mentice AB (publ).
-
What are the bottom 10 Clinical Trials companies in Sweden by Shareholders' Equity ?
The bottom 10 Clinical Trials companies in Sweden by Shareholders' Equity are Prostatype Genomics AB (publ), Orexo AB (publ), SenzaGen AB, Biovica International AB (publ), Iconovo AB (publ), SpectraCure AB (publ), Diamyd Medical AB (publ), Magle Chemoswed Holding AB (publ), Mentice AB (publ) and SynAct Pharma AB.
